Retatrutide is a novel therapeutic/treatment/medicine agent under investigation for the management/treatment/control of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists/glucagon-like peptide-1 receptor agonists/glucose-dependent insulinotropic polypeptide agonists, which work by stimulating/activating/enhancing the r… Read More

Arriving in the arena of excess body fat therapy, retatrutide is a distinct strategy. Unlike many existing medications, retatrutide functions as a double agonist, simultaneously targeting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. This dual engagement encourages various advantageous effects, like b… Read More